<?xml version="1.0" encoding="UTF-8"?>
<ref id="B37-viruses-11-00807">
 <label>37.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dupuy</surname>
    <given-names>L.C.</given-names>
   </name>
   <name>
    <surname>Richards</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Ellefsen</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Chau</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Luxembourg</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Hannaman</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Livingston</surname>
    <given-names>B.D.</given-names>
   </name>
   <name>
    <surname>Schmaljohn</surname>
    <given-names>C.S.</given-names>
   </name>
  </person-group>
  <article-title>A DNA vaccine for Venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates</article-title>
  <source>Clin. Vaccine Immunol.</source>
  <year>2011</year>
  <volume>18</volume>
  <fpage>707</fpage>
  <lpage>716</lpage>
  <pub-id pub-id-type="doi">10.1128/CVI.00030-11</pub-id>
  <?supplied-pmid 21450977?>
  <pub-id pub-id-type="pmid">21450977</pub-id>
 </element-citation>
</ref>
